Logo image of SHFS

SHF HOLDINGS INC (SHFS) Stock Fundamental Analysis

USA - NASDAQ:SHFS - US8244303009 - Common Stock

3.23 USD
+0.05 (+1.57%)
Last: 9/19/2025, 8:00:02 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to SHFS. SHFS was compared to 101 industry peers in the Financial Services industry. SHFS may be in some trouble as it scores bad on both profitability and health. SHFS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year SHFS has reported negative net income.
SHFS had a negative operating cash flow in the past year.
SHFS had negative earnings in 4 of the past 5 years.
In multiple years SHFS reported negative operating cash flow during the last 5 years.
SHFS Yearly Net Income VS EBIT VS OCF VS FCFSHFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of SHFS (-761.56%) is worse than 99.01% of its industry peers.
Industry RankSector Rank
ROA -761.56%
ROE N/A
ROIC N/A
ROA(3y)-142.13%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SHFS Yearly ROA, ROE, ROICSHFS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Operating Margin of SHFS (1.94%) is worse than 71.29% of its industry peers.
The Profit Margin and Gross Margin are not available for SHFS so they could not be analyzed.
Industry RankSector Rank
OM 1.94%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SHFS Yearly Profit, Operating, Gross MarginsSHFS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

0

2. Health

2.1 Basic Checks

SHFS does not have a ROIC to compare to the WACC, probably because it is not profitable.
SHFS has less shares outstanding than it did 1 year ago.
The debt/assets ratio for SHFS is higher compared to a year ago.
SHFS Yearly Shares OutstandingSHFS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
SHFS Yearly Total Debt VS Total AssetsSHFS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -24.35, we must say that SHFS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -24.35, SHFS is not doing good in the industry: 81.19% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -24.35
ROIC/WACCN/A
WACC6.74%
SHFS Yearly LT Debt VS Equity VS FCFSHFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.44 indicates that SHFS may have some problems paying its short term obligations.
The Current ratio of SHFS (0.44) is worse than 65.35% of its industry peers.
SHFS has a Quick Ratio of 0.44. This is a bad value and indicates that SHFS is not financially healthy enough and could expect problems in meeting its short term obligations.
SHFS has a worse Quick ratio (0.44) than 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
SHFS Yearly Current Assets VS Current LiabilitesSHFS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

SHFS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -172.26%.
The Revenue for SHFS has decreased by -24.71% in the past year. This is quite bad
EPS 1Y (TTM)-172.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.64%
Revenue 1Y (TTM)-24.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-52.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SHFS Yearly Revenue VS EstimatesSHFS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M 15M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SHFS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SHFS Price Earnings VS Forward Price EarningsSHFS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

SHFS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.02
SHFS Per share dataSHFS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SHFS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SHF HOLDINGS INC

NASDAQ:SHFS (9/19/2025, 8:00:02 PM)

3.23

+0.05 (+1.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)04-01 2025-04-01
Earnings (Next)N/A N/A
Inst Owners21.92%
Inst Owner Change-78.46%
Ins Owners2.76%
Ins Owner Change0%
Market Cap9.43M
Analysts82.86
Price TargetN/A
Short Float %2.81%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 24.02
EPS(TTM)-18.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS4.49
BVpS-5.8
TBVpS-5.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -761.56%
ROE N/A
ROCE -4.82%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.94%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-142.13%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.97
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 13.51
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.68
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -24.35
F-Score2
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-172.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-52.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y74.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-660.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-327.63%
OCF growth 3YN/A
OCF growth 5YN/A